A valid Parallel Import Product Licence is vital. Without it, you can’t buy, repackage or release stock. Pressure on Regulatory is huge. We can support you - whether its short or long term solutions.
Contact us for more info https://t.co/l9hN9WVOex
#pharma#plpi#regulatory
The pressure on parallel import Regulatory teams to keep licences up to date is huge. We can help to relieve that pressure to keep stocks moving through your unit. Call now to see how we can help https://t.co/l9hN9WVOex #parallelimport#pi#regulatory#regulatoryaffairs#pharma
Watch @DrSarahJarvis discuss medicines, their side-effects, the patient info leaflet & chat with @rickygervais about it: https://t.co/bcK1hU8o8s 👩⚕️
Help us make medicines safer & report any side-effects to us at our #YellowCard page https://t.co/XIl6ZVmeQf
Last week we met with @Noel_Phillips to discuss the dangers involved in buying unlicensed medicines. Catch our Head of Enforcement Alastair Jeffrey this morning on @VictoriaLIVE @ 10am. For tips on how to stay safe buying medicines online, visit https://t.co/dfG4NWF1ok #FakeMeds
Okay, working on this for weeks:
The Ultimate Media Guide to Covering Vaccine Stories
1. Images: You don't have to use photos of a syringe/needle in every story.
2. False balance: Speak to experts. If they agree, that's okay. No need to find a crazy.
ENDS
#vaccineswork
With more than 75 000 reported cases in 2016, #gonorrhoea is the second
most commonly notified sexually transmitted infection in Europe.
Over the past decades, it has developed resistance to several antimicrobial classes.
https://t.co/aG7xImY4K4
#KeepAntibioticsWorking